Surgical Management of Primary Cutaneous Melanoma: Excision Margins and the Role of Sentinel Lymph Node Examination

Surgical Oncology Clinics of North America

Volumn 15, Issue 2, 2006, Pages 301-318

  Thompson, John F ^a,b   Scolyer, Richard A ^a   Uren, Roger F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; LYMPHOSCINTIGRAPHY; MELANOMA; METASTASIS; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SKIN CANCER; SURGICAL TECHNIQUE; TUMOR BIOPSY;

HUMANS; LYMPH NODE EXCISION; MELANOMA; NEOPLASM STAGING; PHYSICAL EXAMINATION; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 33646489653     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2005.12.007     Document Type: Review

References (87)

1. Pringle J.H. A method of operation in melanotic tumours of the skin. Edinb Med J 23 (1908) 496-499
2. Scolyer R, Thompson JF, McCarthy SW, et al. Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis. Australas J Dermatol, in press.
3. Troxel D.B. Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study. Am J Surg Pathol 27 (2003) 1278-1283
4. Coats J. On a case of multiple melanotic sarcoma with remarks on the mode of growth and extension of such tumours. Glasgow Med J 24 (1885) 92-97
5. Snow H. Melanotic cancerous disease. Lancet 2 (1892) 872-874
6. Handley W.S. The pathology of melanotic growths in relation to their operative treatment. Lancet 1 (1907) 927-933 996-1003
7. Olsen G. The malignant melanoma of the skin. New theories based on a study of 500 cases. Acta Chir Scand Suppl 365 (1966) 1-222
8. Heenan P.J. Local recurrence of melanoma. Pathology 36 (2004) 491-495
9. Thomas J.M., Newton-Bishop J., A'Hern R., et al. Excision margins in high-risk malignant melanoma. N Engl J Med 350 (2004) 757-766
10. Milton G.W., Shaw H.M., and McCarthy W.H. Resection margins for melanoma. Aust N Z J Surg 55 (1985) 225-226
11. Veronesi U., and Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg 126 (1991) 438-441
12. Balch C.M., Urist M.M., Karakousis C.P., et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 218 (1993) 262-267
13. Cohn-Cedermark G., Rutqvist L.E., Andersson R., et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer 89 (2000) 1495-1501
14. Khayat D., Rixe O., Martin G., et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer 97 (2003) 1941-1946
15. Johnson T.M., and Sondak V.K. Melanoma margins: the importance and need for more evidence-based trials. Arch Dermatol 140 (2004) 1148-1150
16. NIH Consensus conference. Diagnosis and treatment of early melanoma. JAMA 268 (1992) 1314-1319
17. Haigh P.I., DiFronzo L.A., and McCready D.R. Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis. Can J Surg 46 (2003) 419-426
18. Barzilai D.A., and Singer M.E. The potential impact on melanoma mortality of reducing rates of suboptimal excision margins. J Invest Dermatol 120 (2003) 1067-1072
19. Ross M.I., and Balch C.M. Surgical treatment of primary melanoma. In: Balch C.M., Houghton A.N., Sober A.J., et al. (Eds). Cutaneous melanoma (1998), Quality Medical Publishing, St Louis 141-153
20. Sim F.H., Taylor W.F., Ivins J.C., et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 41 (1978) 948-956
21. Veronesi U., Adamus J., Bandiera D.C., et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49 (1982) 2420-2430
22. Balch C.M., Soong S.J., Bartolucci A.A., et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224 (1996) 255-263
23. Cascinelli N., Morabito A., Santinami M., et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351 (1998) 793-796
24. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
25. Reintgen D., Cruse C.W., Wells K., et al. The orderly progression of melanoma nodal metastases. Ann Surg 220 (1994) 759-767
26. Thompson J.F., McCarthy W.H., Bosch C.M., et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 5 (1995) 255-260
27. Reintgen D., Ross M.I., and Essner R. Sentinel lymph node biopsy: results to date. In: Thompson J.F., Morton D.L., and Kroon B.B. (Eds). Textbook of melanoma (2004), Martin Dunitz, London 365-372
28. Virchow R. Lecture IX: pyaemia and leucocytosis. Chance F, translator. Cellular pathology as based upon physiology and pathological history. New York: Dover Publications, Inc.; 1971. p. 211-29.
29. Braithwaite L.R. The flow of lymph from the ileocaecal angle, and its possible bearing on the cause of duodenal and gastric ulcer. Br J Surg 11 (1923) 7-26
30. Gould E.A., Winship T., Philbin P.H., et al. Observations on a "sentinel node" in cancer of the parotid. Cancer 13 (1960) 77-78
31. Sayegh E., Brooks T., Sacher E., et al. Lymphangiography of the retroperitoneal lymph nodes through the inguinal route. J Urol 95 (1966) 102-107
32. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
33. Bilchik A.J., Giuliano A., Essner R., et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 4 (1998) 351-358
34. de Hullu J.A., Doting E., Piers D.A., et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 39 (1998) 1381-1385
35. Kelemen P.R., Van Herle A.J., and Giuliano A.E. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg 133 (1998) 288-292
36. Keshtgar M.R., Amin A., Taylor I., et al. The sentinel node in anal carcinoma. Eur J Surg Oncol 27 (2001) 113-114
37. Kitagawa Y., Fujii H., Mukai M., et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 80 (2000) 1799-1809
38. Little A.G., DeHoyos A., Kirgan D.M., et al. Intraoperative lymphatic mapping for non-small cell lung cancer: the sentinel node technique. J Thorac Cardiovasc Surg 117 (1999) 220-224
39. Maccauro M., Lucignani G., Aliberti G., et al. Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur J Nucl Med Mol Imaging 32 (2005) 569-574
40. Saha S, Ganatra BK, Gauthier J. Localization of sentinel lymph node in colon cancer. A feasibility study. SSO 50th Annual Cancer Symposium. Chicago, March 20-23, 1997.
41. Wawroschek F., Vogt H., Weckermann D., et al. The sentinel lymph node concept in prostate cancer - first results of gamma probe-guided sentinel lymph node identification. Eur Urol 36 (1999) 595-600
42. Uren R.F., Howman-Giles R., Thompson J.F., et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 4 (1994) 395-399
43. Morton D.L., Wanek L., Nizze J.A., et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 214 (1991) 491-499
44. Alex J.C., Weaver D.L., Fairbank J.T., et al. Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2 (1993) 303-308
45. Essner R, Foshag LJ, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjuvant to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Presented at the Annual Meeting of the Society of Surgical Oncology. Houston (TX), March 17-20, 1994.
46. Thompson J.F., Niewind P., Uren R.F., et al. Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients. Melanoma Res 7 (1997) 500-506
47. Morton D.L., Thompson J.F., Essner R., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg 230 (1999) 453-463
48. Thompson J.F., Uren R.F., Shaw H.M., et al. Location of sentinel lymph nodes in cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 189 (1999) 195-206
49. Uren R.F., Howman-Giles R., and Thompson J.F. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 44 (2003) 570-582
50. Uren RF, Howman-Giles R, Thompson JF. Nuclear medicine. In: Hunt KI, Ross MI, editors. Mastery of lymphatic mapping, in press.
51. Clary B.M., Mann B., Brady M.S., et al. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 8 (2001) 328-337
52. Doting M.H.E., Hoekstra H.J., Plukker J.T., et al. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol 28 (2002) 673-678
53. Gadd M.A., Cosimi A.B., Yu J., et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134 (1999) 381-387
54. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 (1998) 2253-2260
55. Harlow S.P., Krag D.N., Ashikaga T., et al. Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res 11 (2001) 45-55
56. Jansen L., Nieweg O.E., Peterse J.L., et al. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 87 (2000) 484-489
57. Statius Muller M.G., van Leeuwen P.A., de Lange-De Klerk E.S., et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer 91 (2001) 2401-2408
58. Essner R., Conforti A., Kelley M.C., et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6 (1999) 442-449
59. Yee V.S., Thompson J.F., McKinnon J.G., et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12 (2005) 429-439
60. Thomas J.M., and Patocskai E.J. The argument against sentinel node biopsy for malignant melanoma. BMJ 321 (2000) 3-4
61. Thomas J.M., and Clark M.A. Sentinel lymph node biopsy: not yet standard of care for melanoma. BMJ 329 (2004) 170-171
62. Medalie N.S., and Ackerman A.B. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part I. Am J Dermatopathol 25 (2003) 399-417
63. Morton D.L., Cochran A.J., Thompson J.F., et al. Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 (2005) 302-313
64. Morton D.L., Thompson J.F., Cochran A.J., et al. Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma. [ASCO abstract 7500]. J Clin Oncol 23 16 Suppl (2005) 710
65. Morton D.L., and Cochran A.J. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol 151 (2004) 308-319
66. McMasters K.M. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma: an assertion based on comprehensive, critical analysis. Reply. J Am Acad Dermatol 51 (2004) 152-154
67. Estourgie S.H., Nieweg O.E., Valdes Olmos R.A., et al. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 10 (2003) 681-688
68. Thomas J.M., and Clark M.A. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol 30 (2004) 686-691
69. Pawlik T.M., Ross M.I., Johnson M.M., et al. Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy. Ann Surg Oncol 12 (2005) 587-596
70. van Poll D., Thompson J.F., Colman M.H., et al. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma. Ann Surg Oncol 12 (2005) 597-608
71. Pawlik T.M., Ross M.I., Thompson J.F., et al. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 23 (2005) 4588-4590
72. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 10 (2003) 575-581
73. Cochran A.J., Wen D.-R., Huang R.-R., et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 17 (2004) 747-755
74. Dewar D.J., Newell B., Green M.A., et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22 (2004) 3345-3349
75. Fink A.M., Weihsengruber F., Spangl B., et al. S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection. Melanoma Res 15 (2005) 267-271
76. Lee J.H., Essner R., Torisu-Itakura H., et al. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 22 (2004) 3677-3684
77. Ranieri J.M., Wagner J.D., Azuaje R., et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 9 (2002) 975-981
78. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 (2005) 37-47
79. Salti G.I., and Das Gupta T.K. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am J Surg 186 (2003) 98-101
80. Scolyer R.A., Li L.-X.L., McCarthy S.W., et al. Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. Am J Clin Pathol 122 (2004) 532-539
81. Vuylsteke R.J., Borgstein P.J., van Leeuwen P.A., et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 12 (2005) 440-448
82. Starz H., Balda B.R., Kramer K.U., et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 91 (2001) 2110-2121
83. Morton D.L., Cochran A.J., Thompson J.F., et al. Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242 (2005) 302-313
84. Starritt E.C., Uren R.F., Scolyer R.A., et al. Ultrasound examination of sentinel nodes in the initial assessment of patients with primary cutaneous melanoma. Ann Surg Oncol 12 (2005) 18-23
85. Lean C.L., Bourne R., Thompson J.F., et al. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens. Melanoma Res 13 (2003) 259-261
86. Bourne R.M., Stanwell P., Stretch J.R., et al. In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma. Eur J Radiol 53 (2005) 506-513
87. Stretch J.R., Somoraji R., Bourne R., et al. Melanoma metastases in regional lymph nodes accurately detected by proton magnetic resonance spectroscopy of fine needle aspiration biopsies. Ann Surg Oncol 11 (2004) S60